Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination
Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.
Tag Archives: NDMA
-
-
Class Action Claims to Monitor For Zantac Cancer Diagnosis Cleared To Proceed
A federal judge has ruled Zantac class action lawsuits calling for defendants to pay for the costs of medical monitoring for potential cancer, and to be held responsible for consumers'…
-
Zantac MDL Judge To Consider Motion to Dismiss Amended Medical Monitoring Class Action
A federal judge will hear arguments early next month on whether class action lawsuits calling for the makers of Zantac to pay for medical monitoring for consumers who may now…
-
Pfizer Recalling All Chantix Batches Due to Carcinogen in Smoking Cessation Drug
Pfizer has issued a full recall of all Chantix nationwide, due to the presence of potentially cancer-causing chemicals.
-
Zantac Trial Scheduled To Begin October 2022 in California State Court Over Cancer Risk
A California state case may be the first Zantac cancer lawsuit to go before a jury in October 2022.
-
Chantix Class Action Lawsuit Filed Over Cancer-Causing Impurity
A recent Chantix recall has resulted in a class action lawsuit against Pfizer, which claims the company sold a defective drug to consumers which put them at an increased risk…
-
More Chantix Recalled Due To Cancer-Causing Chemicals, As N-Nitroso Varenicline Found in Additional Lots
Pfizer is recalling four additional lots of Chantix due to high levels of a potentially cancer-causing contaminant.
-
New Irbesartan Recalls Announced Abroad Raising Concerns About New “Sartan” Contaminant: Azido
A growing number of international recalls of irbesartan products is raising concerns about a potentially cancer-causing mutagen called azido, which may result in another global hypertension drug recall similar to…
-
Valsartan Lawsuit Alleges Toxic Contamination Led to 8 Different Cancer Diagnoses
A valsartan lawsuit claims the recalled hypertension drug led to eight cancer diagnoses for a New York man.
-
Generic Valsartan Lawsuit Alleges NDMA Exposure Led To Prostate Cancer
A product liability lawsuit claims years of generic valsartan use led to the development of prostate cancer due to the presence of NDMA and other impurities.